Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT05329506 |
| Other study ID # |
2021-1070 |
| Secondary ID |
NCI-2022-00365 |
| Status |
Active, not recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
March 10, 2022 |
| Est. completion date |
February 1, 2026 |
Study information
| Verified date |
April 2024 |
| Source |
M.D. Anderson Cancer Center |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
To learn about the attitudes and beliefs towards vaccination both before and after the
COVID-19 pandemic in patients who have received supportive care.
Description:
Primary Objective:
Our primary objective is to assess patient perception of efficacy and safety of vaccinations.
Secondary Objectives:
To assess demographic predictors of those who would be considered as vaccine hesitant.
To assess patient preferred source of recommendations for or against vaccination.
To assess the role past side effects or allergic reactions play on patient perception of
future vaccines.
To assess patient perception of vaccination prior to COVID-19.
To assess patient willingness to get the COVID-19 vaccine.
To assess patient willingness to get the influenza vaccine.